BLOOD-BASED DNA METHYLATION BIOMARKER PANEL FOR DIAGNOSING COLORECTAL CANCER

摘要

The present application relates to a DNA methylation biomarker panel for diagnosing colorectal cancer, the panel being capable of diagnosing colorectal cancer by detecting and measuring methylation changes of genes in the blood of a patient. The blood-based DNA methylation biomarker panel for diagnosing colorectal cancer, according to the present application, diagnoses colorectal cancer through only blood collection so as to overcome side effects and the inconvenience of having to collect a patient's tissue, thereby enabling the burden on the patient to be minimized.